Cargando…
No Added Value of Duloxetine in Patients With Chronic Pain due to Hip or Knee Osteoarthritis: A Cluster‐Randomized Trial
OBJECTIVE: To assess the effectiveness of duloxetine in addition to usual care in patients with chronic osteoarthritis (OA) pain. The cost‐effectiveness and whether the presence of symptoms of centralized pain alters the response to duloxetine were secondary objectives. METHODS: We conducted an open...
Autores principales: | van den Driest, Jacoline J., Schiphof, Dieuwke, Koffeman, Aafke R., Koopmanschap, Marc A., Bindels, Patrick J. E., Bierma‐Zeinstra, Sita M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313808/ https://www.ncbi.nlm.nih.gov/pubmed/34989159 http://dx.doi.org/10.1002/art.42040 |
Ejemplares similares
-
Effectiveness and cost-effectiveness of duloxetine added to usual care for patients with chronic pain due to hip or knee osteoarthritis: protocol of a pragmatic open-label cluster randomised trial (the DUO trial)
por: van den Driest, Jacoline J, et al.
Publicado: (2017) -
Incidence and Prevalence of Knee Osteoarthritis Using Codified and Narrative Data From Electronic Health Records: A Population‐Based Study
por: Arslan, Ilgin G., et al.
Publicado: (2022) -
Quality indicators for knee and hip osteoarthritis care: a systematic review
por: Arslan, Ilgin G, et al.
Publicado: (2021) -
10-Year natural course of early hip osteoarthritis in middle-aged persons with hip pain: a CHECK study
por: van Berkel, Annemaria C., et al.
Publicado: (2021) -
Risk Assessment for Hip and Knee Osteoarthritis Using Polygenic Risk Scores
por: Sedaghati‐Khayat, Bahar, et al.
Publicado: (2022)